NEWRON PHARMA N/ IT0004147952 /
2024-11-12 5:31:37 PM | Chg. -0.410 | Volume | Bid6:09:20 PM | Ask6:09:20 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.380CHF | -5.26% | 69,033 Turnover: 520,043.290 |
7.260Bid Size: 2,500 | 7.800Ask Size: 459 | 131.7 mill.CHF | - | - |
Newsfile Corp
11-12
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Adams Resources & Energy, Inc. Buyout
Newsfile Corp
11-12
DPZ DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Domino's Pizza, Inc. Investors to Secure ...
Newsfile Corp
11-12
HII Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Huntington Ingalls Industries, Inc....
Newsfile Corp
11-12
PACS Investigation: Kessler Topaz Meltzer & Check, LLP Encourages PACS Group, Inc. (PACS) Investors ...
Newsfile Corp
11-12
ROSEN, A LEADING LAW FIRM, Encourages Lilium N.V. Investors to Secure Counsel Before Important Deadl...
Newsfile Corp
11-12
Millennial Potash Corp Announces Participation in 121 Mining Investment Conference in London
Newsfile Corp
11-12
NFE Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds New Fortress Energy Inc. (NFE) In...
Newsfile Corp
11-12
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Allarity Therapeutics, Inc. In...